NASDAQ:OACCU Oaktree Acquisition Corp. III Life Sciences (OACCU) Stock Price, News & Analysis $11.00 0.00 (0.00%) As of 10/15/2026 Add Share Share Stock Analysis Stock AnalysisChartOwnershipSEC Filings About Oaktree Acquisition Corp. III Life Sciences Stock (NASDAQ:OACCU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OACCU alerts:Sign Up Key Stats Today's Range$11.00▼$11.0050-Day Range$10.84▼$11.0752-Week Range$10.73▼$12.47VolumeN/AAverage Volume957 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Oaktree Acquisition Corp. III Life Sciences is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with a company in the life sciences sector. The company does not operate a traditional business or offer its own products and services. Its activities are centered on raising capital through a public offering and seeking a merger, acquisition, or similar transaction with one or more life sciences businesses. Potential target companies may include businesses involved in pharmaceuticals, biotechnology, medical devices, diagnostics, healthcare services, or related technologies, although the company has not identified a specific target in the available information. Oaktree Acquisition Corp. III Life Sciences is affiliated with Oaktree Capital Management, an investment management firm. The company was established as a blank-check entity and is subject to the customary requirement that any proposed business combination receive approval in accordance with its governing documents and applicable securities regulations. Its filings do not indicate a separate operating footprint or a defined geographic service area.AI Generated. May Contain Errors. Read More Receive OACCU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oaktree Acquisition Corp. III Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OACCU Stock News HeadlinesOaktree Acquisition III Share Redemptions Reshape Capital StructureOctober 15 at 7:31 AM | tipranks.comOaktree Acquisition Appoints Dr. Berry as DirectorOctober 17, 2025 | tipranks.comSee More Headlines OACCU Stock Analysis - Frequently Asked Questions How have OACCU shares performed this year? Oaktree Acquisition Corp. III Life Sciences' stock was trading at $10.61 at the start of the year. Since then, OACCU stock has increased by 3.7% and is now trading at $11.00. When did Oaktree Acquisition Corp. III Life Sciences IPO? Oaktree Acquisition Corp. III Life Sciences (OACCU) raised $175 million in an initial public offering (IPO) on Thursday, October 24th 2024. The company issued 17,500,000 shares at a price of $10.00 per share. Jefferies, Citigroup and UBS Investment Bank served as the underwriters for the IPO. How do I buy shares of Oaktree Acquisition Corp. III Life Sciences? Shares of OACCU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (11m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 OACCU's financial health is in the Green zone, according to TradeSmith. OACCU has been in this zone for over 11 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:OACCU CIK2029769 Webwww.oaktreeacquisitioncorp.com Phone(213) 830-6300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableN/A BetaN/A The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:OACCU) was last updated on 10/15/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredDid you grab your copy yet?Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarte...Profits Run | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.